Information Journal Paper
APA:
Copy. (2020). IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancer. bioRxiv, -(-), 1-35. SID. https://sid.ir/paper/1020240/en
Vancouver:
Copy. IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancer. bioRxiv[Internet]. 2020;-(-):1-35. Available from: https://sid.ir/paper/1020240/en
IEEE:
Copy, “IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancer,” bioRxiv, vol. -, no. -, pp. 1–35, 2020, [Online]. Available: https://sid.ir/paper/1020240/en